Literature DB >> 6983044

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

G Di Chiro, R L DeLaPaz, R A Brooks, L Sokoloff, P L Kornblith, B H Smith, N J Patronas, C V Kufta, R M Kessler, G S Johnston, R G Manning, A P Wolf.   

Abstract

Positron emission tomography was used to measure local cerebral glucose utilization by the 1-[18F]fluoro-2-deoxy-D-glucose technique in 23 patients with cerebral gliomas. All 10 high-grade (III and IV) astrocytomas demonstrated a region of high activity with a glucose consumption of 7.4 +/- 3.5 (SD) mg/100 gm per minute. The 13 low-grade (I and II) gliomas had a glucose metabolic rate of 4.0 +/- 1.8 mg/100 gm per minute, with no distinctly visible hot spot. Thus, we found a correlation between rate of glycolysis and malignancy in primary cerebral tumors. Cerebral cortical glucose utilization was often depressed in areas adjacent to or neurally connected to the tumor site, and there was focal irregular delta wave EEG activity in these areas.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6983044     DOI: 10.1212/wnl.32.12.1323

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  172 in total

Review 1.  Positron emission tomography and the central nervous system.

Authors:  R O Robinson; C D Ferrie; M Capra; M N Maisey
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 2.  18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.

Authors:  G Laking; P Price
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 3.  Positron emission tomography (PET) in the evaluation of patients with cancer.

Authors:  H A Godwin; J H Zuger
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

4.  Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas.

Authors:  Cécile Colavolpe; Philippe Metellus; Julien Mancini; Maryline Barrie; Céline Béquet-Boucard; Dominique Figarella-Branger; Olivier Mundler; Olivier Chinot; Eric Guedj
Journal:  J Neurooncol       Date:  2011-12-15       Impact factor: 4.130

5.  Intraductal oncocytic papillary neoplasm of the pancreas shows strong positivity on FDG-PET.

Authors:  Takehiro Noji; Satoshi Kondo; Satoshi Hirano; Yoshiyasu Ambo; Eichi Tanaka; Chietsugu Katoh; Eriko Tsukamoto; Nagayoshi Tamaki; Hiroyuki Katoh
Journal:  Int J Gastrointest Cancer       Date:  2002

6.  Metabolic patterns in meningiomas.

Authors:  Birgit Herting; Jürgen Meixensberger; Wolfgang Roggendorf; Heinz Reichmann
Journal:  J Neurooncol       Date:  2003-11       Impact factor: 4.130

7.  Prediction of pathology and survival by FDG PET in gliomas.

Authors:  M V Padma; S Said; M Jacobs; D R Hwang; K Dunigan; M Satter; B Christian; J Ruppert; T Bernstein; G Kraus; J C Mantil
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

Review 8.  Applications of positron emission tomography (PET) in neurology.

Authors:  Y F Tai; P Piccini
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

9.  The use of PET in evaluating patients with primary brain tumours: is it useful?

Authors:  W C Olivero; S C Dulebohn; J R Lister
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

10.  Regional glucose utilization and blood flow in experimental brain tumors studied by double tracer autoradiography.

Authors:  A Kato; K Sako; M Diksic; Y L Yamamoto; W Feindel
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.